LakeShore Biopharma Co., Ltd financial statements, including revenue, expenses, profit, and loss
The total revenue of LSB for the last quarter is 18.97 M USD, and it's 20.35% lower compared to the previous quarter. The net income of Q4 23 is -25.47 M USD.